Medtronic and Lilly partner to improve delivery of diabetes
education
5 June 2009
Medtronic, Inc. (NYSE:MDT) and Eli Lilly and Company (NYSE:LLY) have
entered a strategic marketing collaboration to support each other's
commitment to help people with diabetes manage their blood sugar using
insulin therapy.
Working collaboratively with healthcare professionals, Medtronic and
Lilly marketing and sales operations in the United States will work to
improve the delivery of diabetes education for insulin-taking patients
and their caregivers.
This includes the development of new educational resources and
classes around the initiation and intensive management of insulin,
insulin pump therapy and continuous glucose monitoring (CGM).
The alliance combines the insulin expertise of Lilly, a worldwide
leader in diabetes treatment, research and education, with the advanced
diabetes technologies of Medtronic, the world’s largest manufacturer of
insulin pumps and CGM, and maker of an integrated diabetes management
system that combines the power of insulin pump therapy with CGM.
“Medtronic and Lilly are joining together to help improve patient
access to high-quality diabetes education,” said Chris O’Connell,
president of the Diabetes business unit and senior vice president at
Medtronic.
“Because diabetes management is complicated, it is crucial that
physicians and patients have the best access to information and
educational resources. This collaboration will generate greater
awareness and enable more people to benefit from the latest educational
tools regarding insulin pump therapy and continuous glucose monitoring.”
“People with diabetes have numerous treatment options and devices to
help manage blood sugar, but physicians and patients need resources and
solutions to integrate these improvements into real-world therapy,” said
Matt Beebe, Diabetes brand leader, Lilly USA, LLC.
“With this alliance, Lilly and Medtronic hope to create integrated
solutions to address challenges for people taking insulin who need
optimal glycemic control. By joining forces, we will help make insulin
therapy more achievable by offering new educational materials and
resources that help make insulin pump therapy fit into patients’ lives.”
Bookmark this page